Skip to main content
OpenTrials
Completed

NCT Number: NCT01222832

Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge

This study will evaluate the efficacy of a nasopore sponge dressing soaked in Bacitracin VS a sponge soaked in Saline / and the administration of oral antibiotics.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

St. Elizabeth's Medical Center

Brighton, Massachusetts, 02135, United States

About this study

Same as above

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient having primary or revision sinus surgery. Aged 18 years or older.Patients must have middle meatus easily identified. The type of surgery will not be influenced by the participation in this study.

Exclusion criteria

  • Age less then 18
  • Known sensitivity to Bacitracin
  • Pregnancy

Treatment and study plan

Bacitracin

Drug

Bacitracin soaked nasopore sponge

Primary outcomes

  1. Rate of Infection

    Time frame: 90 days

    Number of participants without infections on post-op visits 90 days.

Sponsors and collaborators

Lead sponsor

Steward St. Elizabeth's Medical Center of Boston, Inc.

Other

Registry information

Official study title

Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge After Functional Endoscopic Sinus Surgery

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Oct 18, 2010
Registry last updated
May 31, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.